Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease

Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease

(2012) W.C. Sun et al.   BRITISH JOURNAL OF DERMATOLOGY

Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

(2012) Yoshinao Muro et al.   CLINICAL RHEUMATOLOGY

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

(2012) T. Gono et al.   RHEUMATOLOGY

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody

(2012) Hua Cao et al.   ARTHRITIS CARE & RESEARCH

Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment

(2012) Tsuneyo Mimori et al.   Current Rheumatology Reports

Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission

(2011) Y. Muro et al.   RHEUMATOLOGY

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

(2010) T. Gono et al.   RHEUMATOLOGY

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

Clinical Differences Between Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis and Classic Dermatomyositis

(2009) Hiroshi Mukae et al.   CHEST